You are here
- Home
- Therapy Areas
- Cardiovascular
A 16-Week Randomized, Double-blind, Parallel-group, Multicenter, Placebo- and Active- (Metformin) Controlled Study to Evaluate the Effect on Whole Body Insulin Sensitivity of Tesaglitazar Therapy when Administered to Patients with Type 2 Diabetes
- Disease
- diabetes mellitus
- Drug Name
- Galida
- Generic Name
- galida
- Sponsor
- AstraZeneca
- Drug Status
- Discontinued
- Phase
- II
- Start Date
- Oct 18, 2005
- Study Name
- D6160C09999
- Study Id
- D6160C09999
- ClinicalTrials.gov ID
- NCT00263965
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report Status
- Not Available
